The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
LY-3200882 ID: ALA4594432
Cas Number: 1898283-02-7
PubChem CID: 121249291
Product Number: L414169, Order Now?
Max Phase: Phase
Molecular Formula: C24H29N5O3
Molecular Weight: 435.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Ly 3200882 | Ly-3200882 | Ly3200882 | LY-3200882 | LY3200882
Canonical SMILES: CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccn1
Standard InChI: InChI=1S/C24H29N5O3/c1-24(2,30)21-13-17(5-9-25-21)27-22-14-19(6-10-26-22)32-20-15-29(18-3-4-18)28-23(20)16-7-11-31-12-8-16/h5-6,9-10,13-16,18,30H,3-4,7-8,11-12H2,1-2H3,(H,25,26,27)
Standard InChI Key: PNPFMWIDAKQFPY-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
2.1848 -6.1182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8995 -5.7059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6114 -6.1178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6114 -6.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9012 -7.3549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1848 -6.9468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3259 -7.3556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0403 -6.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0406 -6.1180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7533 -5.7074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4680 -6.1200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4696 -6.9409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7579 -7.3574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7533 -4.8824 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4678 -4.4699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2229 -4.8020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7691 -4.1932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3580 -3.4812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5577 -3.6499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9744 -3.0665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1774 -3.2801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5941 -2.6967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8077 -1.8998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6045 -1.6863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1879 -2.2696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5941 -4.1932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3099 -4.6066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3090 -3.7815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4703 -7.3593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4703 -8.1843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7558 -6.9468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7558 -7.7718 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
7 8 1 0
9 8 2 0
10 9 1 0
11 10 2 0
12 11 1 0
13 12 2 0
8 13 1 0
10 14 1 0
14 15 1 0
16 15 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
19 20 1 0
21 20 1 0
22 21 1 0
23 22 1 0
24 23 1 0
25 24 1 0
20 25 1 0
17 26 1 0
27 26 1 0
27 28 1 0
26 28 1 0
6 29 1 0
29 30 1 0
29 31 1 0
29 32 1 0
M END
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 435.53Molecular Weight (Monoisotopic): 435.2270AlogP: 4.67#Rotatable Bonds: 7Polar Surface Area: 94.32Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.92CX Basic pKa: 7.17CX LogP: 2.83CX LogD: 2.63Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.56Np Likeness Score: -0.76
References 1. Unpublished dataset, 2. Tan B, Zhang X, Quan X, Zheng G, Li X, Zhao L, Li W, Li B.. (2020) Design, synthesis and biological activity evaluation of novel 4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl) oxy) pyridine-2-yl) amino derivatives as potent transforming growth factor-β (TGF-β) type I receptor inhibitors., 30 (16): [PMID:32631540 ] [10.1016/j.bmcl.2020.127339 ] 3. Xu G,Zhang Y,Wang H,Guo Z,Wang X,Li X,Chang S,Sun T,Yu Z,Xu T,Zhao L,Wang Y,Yu W. (2020) Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors., 198 [PMID:32387837 ] [10.1016/j.ejmech.2020.112354 ] 4. Wang Z, Zhang Y, Wang H, Wang X, Yu Z, Zhao L.. (2022) Synthesis and biological evaluation of 4-(pyridine-4-oxy)-3-(tetrahydro-2H-pyran-4-yl)-pyrazole derivatives as novel, potent of ALK5 receptor inhibitors., 61 [PMID:35051574 ] [10.1016/j.bmcl.2022.128552 ]